Pulse: Industry Perspectives

Improving patient centricity by utilizing patient advocacy groups

Monday, May 2, 2016

The Pulse on Patient Recruitment by Ashley Tointon

Patient centricity is a common phrase appearing in the patient recruitment field. Its message is “putting patients first,” which invites more patient input into the clinical trial process, and is one way pharmaceutical companies are actively becoming more patient-centric. Patient engagement can be enhanced by the development of relationships with patient advocacy groups (PAGs).

[Read More]

Collaboration is the key to successful clinical research

Monday, April 25, 2016

The Pulse on Study Conduct by Elizabeth Weeks-Rowe

Without collaboration, there is little opportunity for progress in clinical research. From preclinical to postmarketing research, from project assistant to project lead, from CRO to pharmaceutical sponsors, our commonality is our mutual reliance on each other. All work and efforts throughout a study cycle have the impact of a domino effect. Synchronicity ensures productivity, while division results in chaos and detrimental delays. It is our responsibility to work together to protect study patients and produce credible data, two of the most critical elements of drug development.

[Read More]

Creating and sustaining a value-based culture

Monday, April 18, 2016

The Pulse on Site Success by Christophe Berthoux

As important as the “business” of clinical research is to success, attention to the culture of a research site and the importance of the values that make a site more than a physical structure is a much greater proposition. Why do we have values? The aim of values is multifaceted and the creation of values does not happen overnight. The metamorphosis of values over time can provide meaning, guidance and color to your operation. Organizational change takes time (on average three years) and resources, but the value system you create can impact every facet of the business from resource allocation to hiring processes to the delivery of quality.

[Read More]

Compassionate use and the impact on clinical research

Monday, April 11, 2016

The Pulse on Global Trials by Matthew Howes

Requests for compassionate use of drugs not yet approved by the FDA have been making headlines, and experts predict this trend will continue. Last year, the FDA received 1,262 expanded access requests from drug companies, on behalf of patients, to use unapproved drugs outside of clinical trial programs.

[Read More]

Getting the most from a central advertising campaign

Monday, April 4, 2016

The Pulse on Patient Recruitment by Ashley Tointon

There are few Patient Recruitment and Retention (PRR) tactics that are more controversial than the central advertising campaign. Although central advertising can cover several different mediums such as television, print, radio and online, most users fall into one of two groups: the “it worked” group or the “it didn’t work” group. This dichotomy is pronounced regardless of factors unique to each clinical trial, and hamper efforts to broaden the use of advertising for clinical trials. There are many factors that drive these strong opinions, including cost, the communication of expectations and the accountability of the study sites.

[Read More]

Standing out and succeeding as a new CRA

Monday, March 28, 2016

The Pulse on Study Conduct by Elizabeth Weeks-Rowe

The young woman who stepped into the aisle had an earnest vibrancy about her. She was engaged in a lively phone conversation that continued even while she arranged luggage in the overhead bin and took her seat next to me. Boarding an airplane was secondary to her exciting conversation. From what I could gather, she and some colleagues had resolved a major issue during their business trip. She had performed well and received special recognition from her employer.

[Read More]

Keep your eye on site industry innovation, focus on growth

Monday, March 21, 2016

The Pulse on Site Success by Christophe Berthoux

Dr. Jeffrey Adelglass

I am pleased to have the opportunity this month to thank CenterWatch and our readers for the opportunity to share my views on the exciting changes in the site community over the last two and a half years. It is with great pleasure that I transition the Pulse column to Christophe Berthoux, CEO of the global site management organization, Synexus, as a contributing writer. [Read More]

Logistics issues in clinical trials

Monday, March 14, 2016

The Pulse on Global Trials by Matthew Howes

Most industry experts estimate that supply chain logistics for clinical trials account for 20 to 25% of total R&D costs. There is evidence that those estimates are growing. EvaluatePharma reports that logistics services are experiencing a growth rate of 12%, which is faster than the more stable overall market growth of 2 to 2.5%. With rising cost pressures from payers and policy makers worldwide, it is surprising that more attention has not been paid to this increasingly dominant factor in clinical development.

[Read More]

Making the most of media outreach

Monday, March 7, 2016

The Pulse on Patient Recruitment by Ashley Tointon

Due to the proliferation of clinical research studies and shortened timelines for recruitment, more studies depend on outreach activities to fill the gap between the number of participants needed in a research study and the number of participants a site can recruit within their own network. Media outreach is a ubiquitous tactic occasionally deployed to fill this gap, but it is often met with mixed results. 

[Read More]

Effectively presenting critical study endpoints in an abbreviated timeframe

Monday, February 29, 2016

The Pulse on Study Conduct by Elizabeth Weeks-Rowe

A response to any message must be carefully crafted, considered and reconsidered before being sent, as we all know. One cannot reach into cyberspace and easily recall a transmission. Once the message is received, words therein are part of the proverbial audit trail critical to research documentation. This is why I hovered indecisively over my keyboard after reading a frustrating email from a co-worker that signaled an impending issue.

[Read More]